Журнал «Здоровье ребенка» Том 21, №7, 2026

Актуальність. Здоров’я жінок та дітей є ключовою складовою добробуту населення і сталого розвитку, тому постійна оцінка демографічних даних та показників охорони здоров’я має вирішальне значення для національного планування у сфері охорони здоров’я. Мета: проаналізувати демографічні тенденції та вибрані показники здоров’я матері та дитини в Киргизькій Республіці в контексті реалізації стратегії «Здорові люди — процвітаюча країна» (2019–2030 рр.). Матеріали та методи. Огляд охоплював нормативно-правові документи, а також звіти Міністерства охорони здоров’я та Національного центру охорони здоров’я матері та дитини за 2019–2024 роки. Результати. Виявлено наступні тенденції: у 2024 році було зареєстровано 139 795 новонароджених, а загальний коефіцієнт народжуваності становив 19,4 на 1000 населення порівняно з 20,6 на 1000 населення у 2023 році. Дитяча смертність знизилася з 15,1 на 1000 живонароджених у 2019 році до 14,1 на 1000 живонароджених у 2024 році. Протягом періоду дослідження було впроваджено пренатальний і неонатальний скринінг, зокрема виявлення вродженого гіпотиреозу, фенілкетонурії та адреногенітального синдрому. За результатами також виявлено постійні проблеми, обумовлені доступністю медичної допомоги й діагностичними можливостями. Крім того, зафіксовано прогалини в клінічному мисленні медсестер, їхніх дослідницьких навичках і наставництві. Висновки. Серед постійних проблем — діагностика і доступність послуг при хронічних та онкологічних захворюваннях. Продовжують викликати занепокоєння урогенітальні інфекції та низька схильність до звернення за медичною допомогою серед підлітків, тоді як у дітей переважають паразитарні інвазії та надмірна діагностика. Для забезпечення сталого прогресу необхідні інвестиції в скринінг, інфраструктуру, розвиток кадрового потенціалу й підвищення якості.

Background. The health of women and children is a key component of population well-being and sustainable development, making continuous assessment of demographic and healthcare indicators essential for national health planning. The aim of this study was to analyse demographic trends and selected maternal and child health indicators in the Kyrgyz Republic in the context of implementing the “Healthy People — Prosperous Country” strategy (2019–2030). Materials and methods. The study analysed regulatory documents, as well as reports of the Ministry of Health and the National Center of Maternity and Childhood Care for 2019–2024. Results. The following trends were identified: in 2024, 139,795 newborns were registered and the crude birth rate was 19.4 per 1,000 population, compared with 20.6 per 1,000 population in 2023. Infant mortality decreased from 15.1 per 1,000 live births in 2019 to 14.1 per 1,000 live births in 2024. Prenatal and neonatal screening, including detection of congenital hypothyroidism, phenylketonuria, and adrenogenital syndrome, was implemented during the study period. The findings also highlighted persistent challenges in healthcare accessibility and diagnostic capacity. However, gaps in nurses’ clinical reasoning, research skills, and coaching were identified. Conclusions. Persistent challenges included diagnosis and accessibility of services for chronic and oncological diseases. Among adolescents, urogenital infections and low healthcare-seeking behaviour remained concerns, while parasitic infestations and overdiagnosis were prevalent among children. Investment in screening, workforce development, and quality improvement are needed to sustain progress.

материнська смертність; неонатальні наслідки; перинатальні втручання; програми скринінгу; первинна медична допомога

maternal mortality; neonatal outcomes; perinatal interventions; screening programmes; primary healthcare

1. Children’s Hospital Association. Pediatric workforce shortages persist in 2024. 2024 Aug. Available from: https://www.childrenshospitals.org/content/public-policy/fact-sheet/pediatric-workforce-shortages-persist-in-2024.
2. Zhang X, Liu J, Ni Y, et al. Global prevalence of overweight and obesity in children and adolescents: a systematic review and meta-analysis. JAMA Pediatr. 2024 Aug;178(8):800-813. doi: 10.1001/jamapediatrics.2024.1576.
3. Moldoisaeva S, Kaliev M, Sydykova A, et al. Kyrgyzstan: health system review. In: Rechel B, ed. Health Systems in Transition. Copenhagen: World Health Organization, European Observatory on Health Systems and Policies; 2022 Sep. Available from: https://iris.who.int/bitstream/handle/10665/363175/9789289059237-eng.pdf?sequence=1.
4. Shukurova VK, Boronbayeva EK, Subanbayeva GM. Analysis of quality indicators of medical services for children in short term stay departments at the level of healthcare organizations in Batken, Jalal-Abad, Osh regions and Osh city. Healthc Kyrgyzstan. 2023 May;(4):189-197. doi: 10.51350/zdravkg2022.4.10.27.189.
5. Salmorbekova R, Karimova K, Cholponbaeva V. Children with disabilities in Kyrgyzstan: necessary reforms in social policy. Soc Policy Soc Partnership. 2025 Jun;(6):437-444. doi: 10.33920/pol-01-2506-07.
6. National Statistical Committee of the Kyrgyz Republic. Permanent population at the beginning of the year (thousands of people). 2025. Avai–lable from: https://stat.gov.kg/ru/opendata/category/39/.
7. Cabinet of Ministers of the Kyrgyz Republic. Regulation No. 142: On the National Centre for Maternal and Child Health under the Ministry of Health of the Kyrgyz Republic. 2024 Mar. Available from: https://cbd.minjust.gov.kg/230003592/edition/5310/ru.
8. Kyrgyz Republic. Law No. 14: On the Protection of Citizens’ Health in the Kyrgyz Republic. 2024. Available from: https://cbd.minjust.gov.kg/4-5260/edition/1939/ru.
9. Government of the Kyrgyz Republic. Programme for public health protection and healthcare system development for 2019–2030, “Healthy People — Prosperous Country”. 2018 Dec. Available from: https://cbd.minjust.gov.kg/12976/edition/929710/kg.
10. Ministry of Health of the Kyrgyz Republic. Control and prevention strategy for oncological disease in the Kyrgyz Republic for 2021–2025. 2021. Available from: https://www.iccp-portal.org/resources/control-and-prevention-strategy-oncological-disease-kyrgyz-republic.
11. Rechel B, Moldoisaeva S, Shriwise A. Determinants of maternal mortality rate in Kyrgyz Republic regions. In: Health Systems in Action (HSiA) Insights — Kyrgyzstan. Copenhagen: European Observatory on Health Systems and Policies, WHO Regional Office for Europe; 2025 Jan. Available from: https://iris.who.int/bitstream/handle/10665/380268/9789289059817-eng.pdf?sequence=1.
12. Yang SH, Jeon H, Kim S, et al. Nursing core competencies and educational needs in the low- and middle-income country: a cross-sectional study. Nurse Educ Today. 2024 Dec;143:106349. doi: 10.1016/j.nedt.2024.106349.
13. Rowe SY, Ross-Degnan D, Peters DH, et al. The effectiveness of supervision strategies to improve health care provider practices in low- and middle-income countries: secondary analysis of a systematic review. Hum Resour Health. 2022 Jan;20(1). doi: 10.1186/s12960-021-00683-z.
14. Peabody JW, Oskombaeva K, Shimarova M, et al. A nationwide program to improve clinical care quality in the Kyrgyz Republic. J Glob Health. 2020 Dec;10(2):020418. doi: 10.7189/jogh.10.020418.
15. Cirri L, Uulu AB, Shakiev N, et al. Sleep medicine in the Kyrgyz Republic: past, present and future. J Clin Sleep Med. 2024 Jul;20(7):1213-1216. doi: 10.5664/jcsm.11156.
16. Laatikainen T, Inglin L, Chonmurunov I, et al. National electronic primary health care database in monitoring performance of primary care in Kyrgyzstan. Prim Health Care Res Dev. 2022 Feb;23:e6. doi: 10.1017/S1463423622000019.
17. Gulamov I, Abylov K, Raiimbek UN, et al. Indicators of morbidity and mortality from cardiovascular diseases of rural population in the Osh region (Kyrgyz Republic). Univ Soc. 2024 May;16(3):357-364.
18. Balakrishnan VS. COVID-19 response in Central Asia. Lancet Microbe. 2020 Nov;1(7):e281. doi: 10.1016/S2666-5247(20)30177-4.
19. Muratalieva E, Ablezova M, Djamangulova T, et al. Addressing non-communicable diseases in primary healthcare in Kyrgyzstan: a study on population’s knowledge and behavioral changes. Int J Public Health. 2023 Jul;68:1605381. doi: 10.3389/ijph.2023.1605381.
20. Zhamantayev O, Kayupova G, Nukeshtayeva K, et al. COVID-19 pandemic impact on the maternal mortality in Kazakhstan and comparison with the countries in Central Asia. Int J Environ Res Public Health. 2023 Jan;20(3):2184. doi: 10.3390/ijerph20032184.
21. Koshukeeva MK, Alekseev VP. Adolescent health contemporary trends in the world and Kyrgyzstan. Heart Vessels Transplant. 2025 Jun;9(3):9. doi: 10.24969/hvt.2025.576.
22. Stephenson T. Importance and benefits of investing in child health and research. Glob Pediatr. 2024 Sep;9:100217. doi: 10.1016/j.gpeds.2024.100217.
23. Bowden SA, Goldis M. Congenital hypothyroidism. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2025.
24. Osmonbaeva N, Bloch J, Erkinbaeva A, et al. Microbiological aetiology of paediatric respiratory tract infections in Kyrgyzstan. BMC Infect Dis. 2025 Feb;25(1):280. doi: 10.1186/s12879-025-10668-1.
25. Aziz N, He J, Sarker T, et al. Exploring the role of health expenditure and maternal mortality in South Asian countries: an approach towards shaping better health policy. Int J Environ Res Public Health. 2021 Nov;18(21):11514. doi: 10.3390/ijerph182111514.
26. Kamchybekova TK, Baiyzbekova DA. Impact of the –COVID-19 pandemic on women’s reproductive health. Healthc Kyrgyzstan. 2024;(1): 79-84.
27. Kamali M, Wright JE, Akseer N, et al. Trends and determinants of newborn mortality in Kyrgyzstan: a countdown country case study. Lancet Glob Health. 2021 Mar;9(3):e352-e360. doi: 10.1016/S2214-109X(20)30460-5.
28. Madmarov N, Bayrak M. Determinants of maternal mortality rate in the Kyrgyz Republic regions. In: International Conference of Eurasian Economies. 2017 Oct. 373-382. doi: 10.36880/c09.02001.
29. Suyunbaevna EG, Kozmanbetovna TA, Dosbaevna KK, et al. Physical activity during pregnancy: impacts on maternal health and childbirth outcomes in Kyrgyzstan. J Adv Pharm Educ Res. 2024 Jul-Sep;14(3):119-124. doi: 10.51847/vsd5cjph0s.
30. Aoki ES, Yin R, Li K, et al. National screening programs for cervical cancer in Asian countries. J Gynecol Oncol. 2020 May;31(3):e55. doi: 10.3802/jgo.2020.31.e55.
31. Vaninov A, Ibraimova D, Sharshenbaeva A, et al. Trends in the prevalence and mortality of cervical cancer in the Kyrgyz Republic. Cureus. 2024 Apr;16(4):e57863. doi: 10.7759/cureus.57863.
32. Makimbetov E, Burgoeva M, Sultangazieva B, et al. The state of palliative care for cervical cancer in the Osh region of the Kyrgyz Republic. Int J Gynecol Cancer. 2022 Dec;32(Suppl 1):A80. doi: 10.1136/ijgc-2022-igcs.169.
33. Mamakeev K, Ashimov Z, Talaibekova A, et al. Simultaneous surgery and management in patients with chronic cholecystitis and gynecological diseases. Asian J Pharm. 2024 Jul-Sep;18(3):952-955. doi: 10.22377/ajp.v18i3.5652.
34. Isakova JK. Features of gynecological morbidity and menstrual cycle in adolescent girls in high mountain conditions. Health Soc. 2023 Dec;12(1):1-3. doi: 10.22141/2306-2436.12.1.2023.300.
35. Mambetova M, Dzholbunova Z, Bayalieva M, et al. Clinical and epidemiological characteristics of human metapneumovirus infection in children in Kyrgyzstan. J Commun Dis. 2024 Jun;56(2):15-21. doi: 10.24321/0019.5138.202427.
36. Tagaev T. Prevalence and determinants of intestinal parasitic infections in children from four cities in Kyrgyz Republic. J Commun Dis. 2024 Jan;56(1):152-158. doi: 10.24321/0019.5138.202420.
37. Isaeva E, Bloch J, Akylbekov A, et al. C-reactive protein testing in primary care and antibiotic use in children with acute respiratory tract infections in Kyrgyzstan: an open-label, individually randomised, controlled trial. Lancet Reg Health Eur. 2025 Jan;51:101184. doi: 10.1016/j.lanepe.2024.101184.
38. Skripsiana NS, Nursantari W, Heriyani F, et al. Identification of the cause of infant mortality in Balangan Regency South Kalimantan Province in 2023. Med Periodicals. 2025 Feb;21(1):9. doi: 10.20527/jbk.v21i1.22045.
39. Jelly P, Sharma SK, Saxena V, et al. A comprehensive review of causes and determinants of maternal and infant morta–lity in Uttarakhand. J Health Manag. 2023 Jun;25(2):291-298. doi: 10.1177/09720634231175747.
40. Ferreira TLDS, Da Silva Costa K, Da Silva RAR, et al. Infant mortality in Brazil from 2000 to 2020: a study of spatial and trend analysis. BMC Public Health. 2025 Mar;25(1):948. doi: 10.1186/s12889-025-22066-y.
41. Turayev BSh, Ochilova GSh, Toshpulatova GU. Infant mortality in the Republic of Uzbekistan. J Med Pharm. 2024 Dec;7(12):28-33. doi: 10.5281/zenodo.14544243.
42. Sabyrdilda Z, Kosherbayeva L, Qumar A, et al. Situational analysis of maternal and infant mortality in Kazakhstan. Cent Asian J Med Hypotheses Ethics. 2024 Aug;5(3):149-162. doi: 10.47316/cajmhe.2024.5.3.01.
43. Abdusamatzoda ZM, Ikromov TS, Nabiev ZN, et al. Main factors of infant mortality in different regions of the Republic of Tajikistan. Health Care Tajikistan. 2024 Aug;(2):5-12. doi: 10.52888/0514-2515-2024-361-2-5-12.
44. Popov SV, Profatylo AO, Turner MA, et al. Features of the progression of the inflammatory response in newborns with neonatal encephalopathy. East Ukr Med J. 2024 Mar;12(1):50-60. doi: 10.21272/eumj.2024;12(1):50-60.
45. Kasian S, Loboda A, Smiyan O, et al. The lead content in biological media term infants with hypoxic-ischemic CNS. Bangladesh J Med Sci. 2021 Feb;20(2):330-333. doi: 10.3329/bjms.v20i2.51543.
46. Ilmuratova S, Manzhuova L, Bazarbayeva A, et al. Focus on the endocrine system of children born after reproductive technologies in Kazakhstan. Qatar Med J. 2025 Feb;2025(1):9. doi: 10.5339/qmj.2025.9.
47. Ilmuratova SK, Lokshin VN, Manzhuova LN, et al. Beyond the womb: a study on psychomotor skills and neuropathology in children born after assisted reproductive technologies. Gynecology, Obstetrics and Perinatology. 2024 Sep;23(4):5-11. doi: 10.20953/1726-1678-2024-4-5-11.
48. Lokshin VN, Suleimenova MD, Akhmetova AA, et al. Assisted reproductive technologies in Kazakhstan (National Registry Data, 2021). Reprod Med Cent Asia. 2025 Apr;1:10-19. doi: 10.37800/RM.1.2025.443.
49. Zelinka-Khobzey MM, Tarasenko KV, Nesterenko LA. Characteristics of the condition of newborns from women with preeclampsia, physiological weight and obesity. Ukr J Med Biol Sport. 2022 May;7(2):101-108. doi: 10.26693/jmbs07.02.101.
50. Kusaynov A, Bozhbanbayeva N, Altynbaeva G, et al. Neonatal and infant mortality in the Almaty Region: dynamic analysis and approaches to optimizing the organization of medical care. Reprod Med Cent Asia. 2026 Mar;1:156-164. doi: 10.37800/RM.1.2026.721.
51. Tabyshova A, Uzakbaev K, Abduvalieva S, et al. Survival analysis of newborns with low birth weight (very and extremely low) in Kyrgyzstan. Int J Child Health Nutr. 2026 Jun;15(3):160-170. doi: 10.6000/1929-4247.2026.15.03.4.
52. Nagaraju CS, Naganoor R, Charki S, et al. Role of recombinant human erythropoietin in neonates with moderate to severe hypoxic ischemic encephalopathy — a prospective cohort study. Int J Child Health Nutr. 2025 Aug;14(3):221-228. doi: 10.6000/1929-4247.2025.14.03.3.
53. Zhurakivska O, Yarotska Y, Govsieiev D, et al. Pathomorphological patterns of placental dysfunction in late manifestation of fetal growth restriction. Acta Med Litu. 2025 Dec;32(2):301-312. doi: 10.15388/Amed.2025.32.2.21.
54. Mamed-Zade GT. Probability of fetus congenital malformations forming in women with miscarriages in the anamnesis. Gazz Med Ital Arch Sci Med. 2023 Dec;182(12):973-979. doi: 10.23736/S0393-3660.23.05092-1.
55. Raimkulov K, Zhekshenbekova A, Sharsheeva B. Assessment of behavioral risk factors for parasitic diseases in children in Bishkek schools of the Kyrgyz Republic. Eurasian Health J. 2024 May;16(2):28-35. doi: 10.54890/1694-8882-2024-2-28.
56. Stakeeva C, Zholdoshbekova G, Amiraeva Zh, et al. Impact of COVID-19 on maternal mortality in the Kyrgyz Republic. Eurasian Health J. 2024 May;16(2):134-140. doi: 10.54890/1694-8882-2024-2-134.
57. Maamatova B, Orunbaeva B, Bolokbaeva R, et al. Current trends and epidemiological features of genitourinary diseases in the Osh region. J Hum Biol Clin Med. 2026 Feb;2(1):18-27. doi: 10.63621/jhbcm/1.2026.18.
58. Beniuk V, Komar V, Nykoniuk T, et al. The effect of preventive therapy on cerebrovascular reactivity and uterine artery hemodynamics in primigravidas at high risk of developing preeclampsia. Med Sci Ukr. 2025 Dec;21(4):3-12. doi: 10.32345/2664-4738.4.2025.01.
59. Beniuk V, Hychka N, Dyndar O, et al. Analysis of the first trimester of pregnancy course in women with a history of antenatal fetal death against the background of the proposed pregravidal complex. Med Sci Ukr. 2025 Dec;21(3):16-23. doi: 10.32345/2664-4738.3.2025.02.
60. Janbakhishov TG, Aliyeva EM, Gurbanova FA, et al. Impact of immunization prophylaxis on the course of pregnancy in Rh-negative women. Ukr J Med Biol Sport. 2022 Jun;7(3):114-119. doi: 10.26693/jmbs07.03.114.
61. Khudoyarova D, Yusupov O, Shopulotova Z, et al. Integrated approach to the diagnosis and prevention of varicose veins in pregnant women. Bratisl Lek Listy. 2025 Sep;126(12):3514-3526. doi: 10.1007/s44411-025-00328-w.
62. Asati S, et al. Development and validation of a clinical risk score for predicting postpartum hemorrhage in women with antepartum hemorrhage. J Mother Child. 2026 Apr;30(1):81-92. doi: 10.34763/jmotherandchild.20263001.d-25-00041.
63. Mason M, et al. Improving access to prenatal care of high-risk pregnant women in Houston, Texas: the role of nurse driven care management. J Mother Child. 2025 Jul;29(1):55-62. doi: 10.34763/jmotherand–child.20252901.d-25-00002.
64. Onalbayeva L, Bozhbanbayeva N. Improving the organization of maternity and childhood services in Kazakhstan: current challenges and prospects. Reprod Med Cent Asia. 2026 Mar;1:11-18. doi: 10.37800/RM.1.2026.573.